← All Sponsors
SPONSOR

Qian Chu

Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Carcinoma, Non-Small-Cell LungLung CancerChemoradiotherapyPatient-Reported Outcomes (PRO)NSCLCNeoadjuvant Therapy
NCT06001151 Phase 2
Recruiting

Cadonilimab (AK104) Plus Chemotherapy as First-line Treatment in Non-squamous Non-Small Cell Lung Cancer (NSCLC) Patients With Programmed Cell Death Ligand 1 (PD-L1) Negative

Carcinoma, Non-Small-Cell Lung
China View Trial →
NCT07131670
Recruiting

Symptoms Burden in Lung Cancer Patients Undergoing Definitive Chemoradiotherapy: Insights From Electronic Patient-Reported Outcomes

Lung Cancer
China View Trial →
NCT07388771
Recruiting

Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）

NSCLC
China View Trial →